🔎 Trials Near Me

Home › Hemophilia › Michigan

Pag-aaral pangklinika para sa Hemophilia sa Michigan

5 pag-aaral para sa Hemophilia ang naghahanap ng mga kalahok sa mga site sa Michigan.

Mga Lungsod sa Michigan

Opisyal na teksto ng pag-aaral (English)

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Central Michigan Children's Hospital of Michigan, Detroit
  • Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

  • Children's Hospital of Michigan, Detroit
Nagre-recruitObservasyonal na pag-aaral
Edad 6 hanggang 19 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05022459

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  • University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06349473

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

  • University of Michigan Medical School, Ann Arbor
  • Central Michigan University: Children's Hospital of Michigan, Mount Pleasant
Nagre-recruitPhase 1
Edad 0 hanggang 90 · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT05500807

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

  • Children's Hospital of Michigan, Detroit
  • Henry Ford Health System, Detroit
  • MSU Center for Bleeding and Clotting Disorders, Lansing
Nagre-recruitPhase 4
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT04647227

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.